Single intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 1064-1071

  Wang, Cheng Haung ^a,b   Liang, Chung Ling ^c   Huang, Li Tung ^a   Liu, Jong Kang ^b   Hung, Pei Hua ^a   Sun, Angel ^a   Hung, Kuo Sheng ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL UNITED HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Erythropoietin; Gene therapy; Glial activation; Hypoxic ischemic injury; Water maze task

Indexed keywords

NAKED DNA; RECOMBINANT DNA; RECOMBINANT ERYTHROPOIETIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN HYPOXIA; BRAIN VASOSPASM; CELL ACTIVATION; CONTROLLED STUDY; CORPUS CALLOSUM; DNA TRANSFECTION; DRUG BLOOD LEVEL; DRUG EFFECT; EVALUATION; GENE THERAPY; GLIA CELL; MALE; MAZE TEST; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SINGLE DRUG DOSE;

CYTOMEGALOVIRUS;

EID: 0942268162     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.005     Document Type: Article

References (30)

1. Vargha-Khadem F., Gadian D.G., Watkins K.E., Connelly A., Van Paesschen W., Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science. 277:1997;376-380.
2. Dell'Anna M.E., Calzolari S., Molinari M., Iuvone L., Calimici R. Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behav. Brain Res. 45:1991;125-134.
3. Levine S. Anoxic-ischemic encephalopathy in rats. Am. J. Pathol. 36:1960;1-17.
4. Cheng Y., Deshmukh M., D'Costa A., Demaro J.A., Gidday J.M., Shah A., Sun Y., Jacquin M.F., Johnson E.M., Holtzman D.M. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101:1998;1992-1999.
5. Cheng Y., Gidday J.M., Yan Q., Shah A.R., Holtzman D.M. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann. Neurol. 41:1997;521-529.
6. Dugan L.L., Turetsky D.M., Du C., Lobner D., Wheeler M., Almli C.R., Shen C.K., Luh T.Y., Choi D.W., Lin T.S. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA. 94:1997;9434-9439.
7. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. (Berl). 101:2001;271-276.
8. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19:1999;643-651.
9. Sasaki R., Masuda S., Nagao M. Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci. Biotechnol. Biochem. 64:2000;1775-1793.
10. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., Masuda S., Sasaki R. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253:1998;26-32.
11. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA. 95:1998;4635-4640.
12. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 76:1997;105-116.
13. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA. 97:2000;10526-10531.
14. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., Rustenbeck H.H., Breiter N., Jacob S., Knerlich F., Bohn M., Poser W., Ruther E., Kochen M., Gefeller O., Gleiter C., Wessel T.C., De Ryck M., Itri L., Prange H., Cerami A., Brines M., Siren A.L. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8:2002;495-505.
15. Stohlawetz P.J., Dzirlo L., Hergovich N., Lackner E., Mensik C., Eichler H.G., Kabrna E., Geissler K., Jilma B. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood. 95:2000;2983-2989.
16. Liu F., Song Y., Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1999;1258-1266.
17. Crystal R.G. Transfer of genes to humans: early lessons and obstacles to success. Science. 270:1995;404-410.
18. Li K., Welikson R.E., Vikstrom K.L., Leinwand L.A. Direct gene transfer into the mouse heart. J. Mol. Cell. Cardiol. 29:1997;1499-1504.
19. Jeltsch H., Bertrand F., Lazarus C., Cassel J.C. Cognitive performances and locomotor activity following dentate granule cell damage in rats: role of lesion extent and type of memory tested. Neurobiol. Learn. Mem. 76:2001;81-105.
20. Paxinos G., Waston C. The Rat Brain in Stereotaxic Coordinates. second ed. 1986;Academic Press, Sydney.
21. Aydina A., Genc K., Akhisaroglub M., Yorukogluc K., Gokmend N., Gonullu E. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain & Dev. 27:2003;494-498.
22. Kumral A., Ozer E., Yilmaz O., Akhisaroglu M., Gokmen N., Duman N., Ulukus C., Genc S., Ozkan H. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol. Neonate. 83:2003;224-228.
23. Jelkmann W. The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP. Eur. J. Haematol. 69:2002;265-274.
24. Wiessner C., Allegrini P.R., Ekatodramis D., Jewell U.R., Stallmach T., Gassmann M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J. Cereb. Blood Flow Metab. 21:2001;857-864.
25. Wolf R.F., Peng J., Friese P., Gilmore L.S., Burstein S.A., Dale G.L. Erythropoietin administration increases production and reactivity of platelets in dogs. Thromb. Haemostasis. 78:1997;1505-1509.
26. Wolf R.F., Gilmore L.S., Friese P., Downs T., Burstein S.A., Dale G.L. Erythropoietin potentiates thrombus development in a canine arterio-venous shunt model. Thromb. Haemostasis. 77:1997;1020-1024.
27. Romijn H.J., Hofman M.A., Gramsbergen A. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby. Early Hum. Dev. 26:1991;61-67.
28. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20:1997;570-577.
29. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M.L., Ghezzi P. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952:2002;128-134.
30. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami A., Coleman T.R., Brines M., Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198:2003;971-975.